Markets Gone Wild

Welcome to New York City Investigation into Vicor Corporation New York City, NY / ACCESSWIRE / December 30, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vicor Corporation (“Vicor” or “the Company”) (NASDAQ:VICR). Investors who purchased Vicor securities prior to April 26, 2023, and continue to hold…

Exciting Partnership Announcement in Biopharmaceutical Industry Y-mAbs Therapeutics, Inc. and Nobelpharma Co., Ltd. Team Up New York, Nov. 4, 2024 In a recent press release, Y-mAbs Therapeutics, Inc. and Nobelpharma Co., Ltd. have made waves in the biopharmaceutical industry by announcing an exclusive license and distribution agreement. This collaboration focuses on the development and commercialization…

Hims & Hers: Strong Revenues Amidst Profit-Taking and Fluctuating EBITDA Margins Hims & Hers Health Inc., a leading telemedicine and direct-to-consumer healthcare company, recently experienced a sell-off due to profit-taking and weaker-than-expected EBITDA margins, despite impressive revenue growth. This trend has left some investors questioning the company’s financial health and future prospects. Financial Performance As…

Welcome to a Friendly and Informative Blog Post! Hey there, you! Yes, you! Have you ever suffered a loss on your investment? Don’t worry, you’re not alone! So, you’ve invested in Applied Therapeutics, Inc. (NASDAQ:APLT) and unfortunately, things didn’t turn out as expected. But hey, that’s just a part of the rollercoaster ride that is…